Featured Image

RESEARCH STUDY
FOR TRIGEMINAL NEURALGIA

Consider enrolling in a clinical research study and help us evaluate an investigational drug that has been FDA approved for the prevention of episodic migraine.

Trigeminal neuralgia (TN) causes intense, stabbing, electric shock-like pain on one side of the face. Although TN cannot always be cured, there are some treatments available that may alleviate the debilitating pain. Surgery can be an effective option for those who become unresponsive to medications or for those who suffer serious side effects from the medications.

This study is evaluating rimegepant for the treatment of TN. The study is being conducted at Clinical Research Professionals in Chesterfield.

You may be able to take part if you:

  • Are 18 or older
  • Have a diagnosis of TN
  • Have have had TN symptoms for at least 3 months

Participants receive:

  • Study-related medical care at no cost
  • Study-related medication from a local physician at no cost
  • Compensation up to $450 for time and travel

Featured Image
To contact the study coordinator, please enter the following information:
Please enter first name.
Please enter last name.
Please enter valid email.
Please enter valid mobile number.
Please enter valid zip code.
Your privacy is important to us. By clicking "Submit" you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.